Laryngeal leishmaniasis, a rare manifestation of an emerging disease.
Santa Casa de São Paulo Faculty of Medical Sciences, São Paulo, Brazil. Electronic address: leosilva@uol.com.br.
L
L
Silva
Otolaryngology/Head and Neck Surgery, Associate Professor of Otolaryngology at the Stanford University Medical Center, USA.
E
E
Damrose
Santa Casa de São Paulo Faculty of Medical Sciences, São Paulo, Brazil.
A-M-F
AM
Fernandes
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D021821:Communicable Diseases, Emerging; D004630:Emergencies; D006685:Hoarseness / Q000469:parasitology; D006801:Humans; D007818:Laryngeal Diseases / Q000175:diagnosis* / Q000469:parasitology / Q000628:therapy*; D007892:Leishmania braziliensis / Q000302:isolation & purification*; D007896:Leishmaniasis / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D008875:Middle Aged; D015508:Nasal Obstruction / Q000469:parasitology; D009942:Organometallic Compounds / Q000627:therapeutic use; D011576:Psychodidae; D014139:Tracheostomy / Q000379:methods; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate